/Companies

diaceutics

1 known investors

Find your way into diaceutics

Sign up to see every warm intro you have to diaceutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the diaceutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Diaceutics operates DXRX, a diagnostic commercialization platform that integrates real-world lab, genomic, clinical, claims, and social-determinants data to help pharma and biotech companies commercialize precision-medicine therapies. Its tools identify testing behaviors and engage physicians to close the gap between diagnostic testing and treatment adoption.

Investors · 1

Frequently asked questions

What does diaceutics do?
Diaceutics operates DXRX, a diagnostic commercialization platform that integrates real-world lab, genomic, clinical, claims, and social-determinants data to help pharma and biotech companies commercialize precision-medicine therapies. Its tools identify testing behaviors and engage physicians to close the gap between diagnostic testing and treatment adoption.
Who are diaceutics's investors?
diaceutics's investors include Clarendon Fund Managers Ltd..